Literature DB >> 6450255

Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma).

T Inoshita, T L Whiteside, G P Rodnan, F H Taylor.   

Abstract

Thirty-one patients with PSS (scleroderma) were examined for evidence of abnormalities in T lymphocyte subsets. TG and TM subpopulations of peripheral blood T lymphocytes were enumerated by rosetting techniques. The helper-suppressor functions of these lymphocytes were studied in the PWM-activated in vitro assay. The absolute numbers of TG cells in patients with DS as well as those with the CREST syndrome variant of PSS were decreased in comparison with those in age-matched healthy controls (p < 0.05). The numbers of TM and T "null" cells were not significantly altered (p > 0.05). The reduction in the number of TG cells was not caused by lymphocytotoxic antibodies. The mean helper-suppressor scores for patients with PSS and DS (1.25) and those with CREST syndrome (1.36) were higher (p < 0.05) than the mean score for healthy individuals (0.80). No relationship between the immunoregulatory abnormality and the presence or titer of CICs, ANAs, hypergammaglobulinemia, or various clinical manifestations of PSS could be demonstrated in individual patients. The finding of abnormalities in T lymphocyte subpopulations and the demonstration of their altered functional expression in patients with PSS indicate that immunoregulatory mechanisms may play an important role in this connective tissue disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450255

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  16 in total

1.  Abnormalities of T lymphocyte subsets in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies.

Authors:  A Kahan; A Kahan; F Picard; C J Menkès; B Amor
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

2.  Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis.

Authors:  M Grazia Cifone; R Giacomelli; G Famularo; R Paolini; C Danese; T Napolitano; A Procopio; A M Perego; A Santoni; G Tonietti
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis. II. Effector cells for the enhancing effect of acroscleroderma patients' sera.

Authors:  I J Polakowski; S Majewski; E Skopińska-Rózewska; M Zukowska; B Włodarska; S Jabłońska
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.

Authors:  G Holdstock; B F Chastenay; E L Krawitt
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

5.  Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.

Authors:  E Soppi; A Lehtonen; A Toivanen
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

6.  Detection of antilymphocyte antibodies in patients with scleroderma using three different techniques.

Authors:  M T Labro; A Perianin; M F Kahn
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

7.  Smooth muscle differentiation in scleroderma fibroblastic cells.

Authors:  A P Sappino; I Masouyé; J H Saurat; G Gabbiani
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

8.  Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.

Authors:  Kathryn S Torok; Katherine Kurzinski; Christina Kelsey; Jonathan Yabes; Kelsey Magee; Abbe N Vallejo; Thomas Medsger; Carol A Feghali-Bostwick
Journal:  Semin Arthritis Rheum       Date:  2015-06-17       Impact factor: 5.532

9.  Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases.

Authors:  J Alcocer-Varela; A Laffón; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

10.  Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosis.

Authors:  M D Lockshin; J A Markenson; L Fuzesi; S Kazanjian-Aram; C Joachim; M Ordene
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.